This report was first published by Endpoints News. To see the original version, click here
When Endpoints Signal released the Q1 Biopharma Sentiment Index on Jan. 28, it showed broadly rising confidence across the industry. But beneath those headline gains, there’s a story the numbers alone don’t tell — one that spilled out of the open-text fields of our survey in blunt language.
Of the 988 verified respondents who completed the BPSI survey this quarter, hundreds took the time to write out their views in our comments section. About one in five (169 comments) focused on politics, regulators and the state of the US government.
您已阅读7%（630字），剩余93%（8461字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。